Cas No.: 945245-76-1
PRODUCT INFORMATION
Description
LSD is a peptide-based agent demonstrating selective targeting specificity toward melanoma-derived lymphatic endothelial cells (LECs) in C8161 models, without cross-reactivity to normal tissue lymphatics. Conjugation with pro-apoptotic peptides has been used to study the reduction of tumor lymphatic density in vivo. This peptide serves as a specialized tool for investigating lymphatic-specific molecular interactions and pathways in oncological research models.
Molecular Weight
1009.20
Purity
> 95%
Formula
C₃₉H₇₂N₁₄O₁₃S₂
Product Type
Targeting Peptide
Sequence
Cys-Leu-Ser-Asp-Gly-Lys-Arg-Lys-Cys
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- Rabies Virus Matrix Protein Fragment (RV-MAT) (CAT#: OLY-1025-YS-14)
- Cyclo(Arg-Ala-Asp-(D-Tyr)-Lys) Targeting Peptide (CAT#: OLY-1025-YS-36)
- GPLGLAGGWGERDGS Targeting Peptide (CAT#: OLY-1025-YS-25)
- NGR Targeting Peptide (CAT#: OLY-1025-YS-38)
- M2 Targeting Peptide (CAT#: OLY-1025-YS-40)
- CGGRGD TFA Targeting Peptide (CAT#: OLY-1025-YS-57)
- T9 Targeting Peptide (CAT#: OLY-1025-YS-19)
- MH42 Targeting Peptide (CAT#: OLY-1025-YS-31)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.